- Home
- AMRK vs DNTH Comparison
AMRK vs DNTH Comparison
Compare AMRK & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRK
- DNTH
- Stock Information
- Founded
- AMRK 1965
- DNTH 2015
- Country
- AMRK United States
- DNTH United States
- Employees
- AMRK N/A
- DNTH N/A
- Industry
- AMRK Other Specialty Stores
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- AMRK Industrials
- DNTH Health Care
- Exchange
- AMRK Nasdaq
- DNTH Nasdaq
- Market Cap
- AMRK 500.4M
- DNTH 657.0M
- IPO Year
- AMRK N/A
- DNTH N/A
- Fundamental
- Price
- AMRK $19.73
- DNTH $17.39
- Analyst Decision
- AMRK Buy
- DNTH Strong Buy
- Analyst Count
- AMRK 3
- DNTH 8
- Target Price
- AMRK $33.00
- DNTH $53.00
- AVG Volume (30 Days)
- AMRK 338.1K
- DNTH 255.5K
- Earning Date
- AMRK 05-07-2025
- DNTH 05-12-2025
- Dividend Yield
- AMRK 4.05%
- DNTH N/A
- EPS Growth
- AMRK N/A
- DNTH N/A
- EPS
- AMRK 1.57
- DNTH N/A
- Revenue
- AMRK $10,991,521,000.00
- DNTH $6,524,000.00
- Revenue This Year
- AMRK $19.62
- DNTH N/A
- Revenue Next Year
- AMRK $2.80
- DNTH N/A
- P/E Ratio
- AMRK $12.57
- DNTH N/A
- Revenue Growth
- AMRK 6.78
- DNTH 102.36
- 52 Week Low
- AMRK $19.39
- DNTH $13.37
- 52 Week High
- AMRK $47.39
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- AMRK 35.07
- DNTH 35.86
- Support Level
- AMRK $19.60
- DNTH $17.40
- Resistance Level
- AMRK $21.41
- DNTH $18.45
- Average True Range (ATR)
- AMRK 0.77
- DNTH 1.21
- MACD
- AMRK -0.08
- DNTH -0.22
- Stochastic Oscillator
- AMRK 10.12
- DNTH 10.60
About AMRK A-Mark Precious Metals Inc.
A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales and Ancillary Services; Secured Lending and Direct-to-Consumer. It generates maximum revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Australia, Africa, and other regions.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.